(Q40733350)

23 September 2017

title

Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients (English)

1 reference

23 September 2017

1 reference

W E Evans

1

1 reference

23 September 2017

C B Pratt

2

1 reference

23 September 2017

R H Taylor

3

1 reference

23 September 2017

L F Barker

4

1 reference

23 September 2017

W R Crom

5

1 reference

23 September 2017

publication date

1 January 1979

1 reference

Cancer Chemotherapy and Pharmacology

23 September 2017

published in

1 reference

23 September 2017

volume

3

1 reference

23 September 2017

issue

3

1 reference

23 September 2017

page(s)

161-166

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00262416

23 September 2017

exact match

0 references

cites work

The relative contribution of drug concentration and duration of exposure to mouse bone marrow toxicity during continuous methotrexate infusion

1 reference

12 December 2020

High-dose methotrexate, not a conventional treatment

1 reference

12 December 2020

Methotrexate tissue distribution: prediction by a mathematical model

1 reference

12 December 2020

Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity

1 reference

12 December 2020

"Rescue" techniques in cancer chemotherapy: use of leucovorin and other rescue agents after methotrexate treatment

1 reference

12 December 2020

Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration

1 reference

12 December 2020

Kinetic model for the disposition and metabolism of moderate and high-dose methotrexate (NSC-740) in man

1 reference

12 December 2020

Serum distribution of citrovorum factor and 5-methyltetrahydrofolate following oral and im administration of calcium leucovorin in normal adults

1 reference

12 December 2020

"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue

1 reference

12 December 2020

Methotrexate Pharmacokinetics

1 reference

12 December 2020

Pharmacokinetics of high-dose methotrexate with citrovorum factor rescue

1 reference

12 December 2020

Optimization of high-dose methotrexate with leucovorin rescue therapy in the L1210 leukemia and sarcoma 180 murine tumor models

1 reference

12 December 2020

Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors

1 reference

12 December 2020

Recovery from toxicity associated with high-dose methotrexate: prognostic factors

1 reference

12 December 2020

High dose methotrexate therapy of solid tumors: observations relating to clinical toxicity

1 reference

12 December 2020

Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion pattern

1 reference

12 December 2020

Effective absorption and utilization of oral formyltetrahydrofolate in man

1 reference

12 December 2020

Relative toxicity of methotrexate in several tissues of mice bearing Lewis lung carcinoma

1 reference

12 December 2020

The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides

1 reference

12 December 2020

Effect of pleural effusion on high-dose methotrexate kinetics

1 reference

12 December 2020

Threshold Methotrexate Concentration for In Vivo Inhibition of DNA Synthesis in Normal and Tumorous Target Tissues

1 reference

12 December 2020

Use of Plasma Pharmacokinetics to Predict and Prevent Methotrexate Toxicity

1 reference

12 December 2020

Relative biochemical aspects of low and high doses of methotrexate in mice

1 reference

12 December 2020

High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00262416

1 reference

Dimensions Publication ID

23 September 2017

1036776202

0 references

1 reference